These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11863490)

  • 1. New approaches to diagnosis and management of unstable angina and non-ST segment elevation myocardial infarction: controversial data.
    Borja J; Paz MA; Olivella P
    Arch Intern Med; 2002 Feb; 162(4):485-6. PubMed ID: 11863490
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.
    Cohen M
    J Thromb Thrombolysis; 2001 Apr; 11(2):171-4. PubMed ID: 11406733
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-molecular-weight heparin in patients with non-ST-segment elevation acute coronary syndrome: role in the emergency department.
    Goodman SG
    J Emerg Med; 2000 Oct; 19(3 Suppl):3S-11S. PubMed ID: 11050378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-molecular-weight heparins in unstable angina and non-Q-wave myocardial infarction].
    Rubio-Terrés C; Pajuelo F; Margalet I
    Med Clin (Barc); 2001 May; 116(16):638-9. PubMed ID: 11412657
    [No Abstract]   [Full Text] [Related]  

  • 5. New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction.
    O'Rourke RA; Hochman JS; Cohen MC; Lucore CL; Popma JJ; Cannon CP
    Arch Intern Med; 2001 Mar; 161(5):674-82. PubMed ID: 11231699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparins for unstable angina and non-ST segment elevation myocardial infarction.
    Hitzeman N; Rafii F
    Am Fam Physician; 2009 Apr; 79(7):560-2. PubMed ID: 19378871
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment strategy of unstable angina and non-ST-segment elevation myocardial infarction].
    Zaliūnas R
    Medicina (Kaunas); 2002; 38 Suppl 2():11-4. PubMed ID: 12560610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin.
    Antman EM; Kereiakes DJ
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E1-4;discussion E25-8. PubMed ID: 11156721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease.
    Sätre H; Holmvang L; Wagner GS; Lindahl B; Wallentin L
    Eur Heart J; 1999 May; 20(9):645-52. PubMed ID: 10208784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mexican Cardiology Society Guidelines on the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. Cancún, Quintana Roo 15-16 November 2002. Cooperative Group of Consensus].
    Lupi-Herrera E;
    Arch Cardiol Mex; 2002; 72 Suppl 2():S5-44. PubMed ID: 12661524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction.
    Monrad ES
    Am J Cardiol; 2000 Apr; 85(8A):2C-9C. PubMed ID: 10793174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of low-molecular-weight heparins in the treatment of acute coronary syndrome].
    Carlsson J; Tebbe U
    Dtsch Med Wochenschr; 2002 Apr; 127(16):859-65. PubMed ID: 11961704
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. A panel discussion with audience participation.
    Chesebro JH; Verheugt FW; Kontny F; Fry ET; Wallentin L; Camm AJ; Bechtold H
    Clin Cardiol; 2001 Mar; 24(3 Suppl):I20-2. PubMed ID: 11286311
    [No Abstract]   [Full Text] [Related]  

  • 14. New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion.
    Howard PA
    Ann Pharmacother; 2002 Nov; 36(11):1800-4. PubMed ID: 12432893
    [No Abstract]   [Full Text] [Related]  

  • 15. Defining the scope of evidence-based practice for low-molecular-weight heparin therapy in high-risk patients with unstable angina and non-ST-elevation myocardial infarction.
    Ferguson JJ
    Clin Cardiol; 2002 Nov; 25(11 Suppl 1):I16-22. PubMed ID: 12428815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute management of unstable angina and non-ST segment elevation myocardial infarction.
    Silva FM; Pesaro AE; Franken M; Wajngarten M
    Einstein (Sao Paulo); 2015; 13(3):454-61. PubMed ID: 26466065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present treatment options for unstable angina and non-Q-wave myocardial infarction.
    Lairikyengbam SK; Davies AG; Anderson MH
    QJM; 2001 Jan; 94(1):5-11. PubMed ID: 11161130
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hirudin is superior to heparin in reducing cardiovascular mortality, infarct and refractory angina in patients with unstable angina or myocardial infarct without elevation of the ST tract].
    Franzosi MG
    Ital Heart J Suppl; 2000 Sep; 1(9):1210-2. PubMed ID: 11140295
    [No Abstract]   [Full Text] [Related]  

  • 20. Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial.
    Chang WC; Harrington RA; Simoons ML; Califf RM; Lincoff AM; Armstrong PW;
    Eur Heart J; 2002 Jul; 23(14):1102-11. PubMed ID: 12090748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.